Journal of Shandong University (Health Sciences) ›› 2019, Vol. 57 ›› Issue (7): 67-71.doi: 10.6040/j.issn.1671-7554.0.2019.180

Previous Articles    

Expression and clinical significance of homo sapiens longevity assurance homologue 2 of yeast LAG1 in colorectal cancer

8.GUO Yan1, ZHANG Zheying2, WANG Yunxi1, WEI Xiaojuan1   

  1. 1. Department of Gastroenterology, Xinxiang Center Hospital, Xinxiang 453000, Henan, China;
    2. Department of Pathophysiology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, Henan, China
  • Published:2022-09-27

PDF (PC)

38

Abstract: Objective To investigate the expression and clinical significance of homo sapiens longevity assurance homologue 2 of yeast LAG1(LASS2)in colorectal cancer. Methods A total of colorectal cancer 85 cases treated during Aug. 2011 and Aug. 2013 were involved. The protein expression of LASS2 in colorectal cancer and adjacent tissues were detected with immunohistochemistry(SP method). All patients were followed up, and until Aug. 30, 2018, the complete follow-up data of 78(91.76%)cases were obtained. Patients’ survival was analyzed using Kaplan-Meier method and Log-rank test. The influencing factors on prognosis were determined with Cox proportional hazards regression model. Results The positive expression rates of LASS2 in colorectal cancer tissues and adjacent tissues was 32.94% vs 78.82%(P<0.001). The positive expression rates of LASS2 in colorectal cancer tissues with moderately poor differentiation, TNM stage Ⅲ+Ⅳ and lymph node metastasis were lower than that in high differentiation, TNM stage Ⅰ+Ⅱ and without lymph node metastasis(P<0.05). The overall survival of patients with positive versus negative LASS2 expression was 57.60 vs 28.47 months(P<0.001), and cumulative survival rate was 55.60% vs 19.60%(P<0.001). The differentiation, TNM stage, lymph node metastasis and protein expression of LASS2 were influencing factors on the 山 东 大 学 学 报 (医 学 版)57卷7期 -郭艳,等.人源性长寿保障基因2在结直肠癌组织中的表达及其临床意义 \=-prognosis(HR=0.134, 2.907, 2.478 and 0.476, P<0.05). Conclusion LASS2 is lowly expressed in colorectal cancer tissues, and is related to the malignant progression and prognosis. It might be a potential biomarker for prognosis assessment.

Key words: Colorectal cancer, Homo sapiens longevity assurance homologue 2 of yeast LAG1, Prognosis, Cox proportional hazard regression model

CLC Number: 

  • R735.3
[1] Murphy CC, Wallace K, Sandler RS, et al. Racial disparities in incidence of young-onset colorectal cancer and patient survival [J]. Gastroenterology, 2019, 156(4): 958-965.
[2] Pang QY, An R, Liu HL. Perioperative transfusion and the prognosis of colorectal cancer surgery: a systematic review and meta-analysis [J]. World J Surg Oncol, 2019, 17(1): 7-13.
[3] 刘童, 张欣, 王传新. IRX5 mRNA在结直肠癌诊断及预后中的价值[J]. 山东大学学报(医学版), 2016, 54(7): 69-74, 87. LIU Tong, ZHANG Xin, WANG Chuanxin. Significance of IRX5 mRNA in the diagnosis and prognosis of colorectal cancer [J]. Journal of Shandong University(Health Sciences), 2016, 54(7): 69-74, 87.
[4] 张静, 王晰程, 沈琳. 分子标志物对Ⅱ期和Ⅲ期结直肠癌术后随访策略的影响[J]. 中华胃肠外科杂志, 2018, 21(6): 716-720. ZHANG Jing, WANG Xicheng, SHEN Lin. Impacts of microsatellite status, RAS and BRAF mutation on postoperative follow-up strategy in stage Ⅱ and Ⅲ colorectal cancer [J]. Chinese Journal of Gastrointestinal Surgery, 2018, 21(6): 716-720.
[5] Yegin Z, Aydin O, Koc H, et al. Expression profiles of proto-oncogene TWIST1 and tumor metastasis suppressor gene LASS2 in bladder cancer [J]. Cell Mol Biol(Noisy-le-grand), 2018, 64(11): 66-73.
[6] 左华楚, 李秀霞, 李时荣, 等. LSAA2/TMSG-1基因沉默对人肺癌95C细胞侵袭迁移机制探讨[J]. 中华肿瘤防治杂志, 2015, 22(24): 1865-1873. ZUO Huachu, LI Xiuxia, LI Shirong, et al. Effect of LASS2/TMSG on the invasion and migration of 95C human pulmonary carcinoma cell [J]. Chinese Journal of Cancer Prevention and Treatment, 2015, 22(24): 1865-1873.
[7] 王鑫, 王忠臣, 孙微微. 血管生成素样蛋白1在结直肠癌中表达的意义及对其生物学行为的影响[J]. 中华普通外科杂志, 2018, 33(4): 326-329. WANG Xin, WANG Zhongchen, SUN Weiwei. Clinicopathological significance and biological behavior of ANGPTLl expression in human colorectal cancer [J]. Chinese Journal of General Surgery, 2018, 33(4): 326-329.
[8] Zhang S, Yang Y, Yan D, et al. Internet videos and colorectal cancer in mainland China: a content analysis [J]. BMC Med Inform Decis Mak, 2018, 18(1): 129-137.
[9] Ott C, Gerken M, Hirsch D, et al. Advanced mucinous colorectal cancer: epidemiology, prognosis and efficacy of chemotherapeutic treatment [J]. Digestion, 2018, 98(3): 143-152.
[10] Gan T, Sinner HF, Walling SC, et al. Impact of the affordable care act on colorectal cancer screening, incidence, and survival in Kentucky [J]. J Am Coll Surg, 2019, 228(4): 342-353.
[11] 刘铭, 王崑, 包全, 等. 肝转移灶个数对结直肠癌肝转移患者术后生存的影响[J]. 中华普通外科杂志, 2018, 33(1): 34-37. LIU Ming, WANG Kun, BAO Quan, et al. Effect of tumor number on the survival of patients of colorectal cancer liver metastases undergoing hepatic resection [J]. Chinese Journal of General Surgery, 2018, 33(1): 34-37.
[12] 朱宇, 王宏洁, 韩彬彬, 等. 人异常凝血酶原(PIVKA-II)在监测结直肠癌肝转移中的应用[J]. 山东大学学报(医学版), 2018, 56(10): 58-63. ZHU Yu, WANG Hongjie, HAN Binbin, et al. A study of serum PIVKA-II in patients with liver metastasis of colorectal cancer [J]. Journal of Shandong University(Health Sciences), 2018, 56(10): 58-63.
[13] Kim H, Jung HI, Kwon SH, et al. Preoperative neutrophil-lymphocyte ratio and CEA is associated with poor prognosis in patients with synchronous colorectal cancer liver metastasis [J]. Ann Surg Treat Res, 2019, 96(4): 191-200.
[14] Wang H, Zuo Y, Ding M, et al. LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity [J]. Oncol Lett, 2017, 13(2): 661-668.
[15] Mei F, You J, Liu B, et al. LASS2/TMSG1 inhibits growth and invasion of breast cancer cell in vitro through regulation of vacuolar ATPase activity [J]. Tumour Biol, 2015, 36(4): 2831-2844.
[16] Fan SH, Wang YY, Wu ZY, et al. AGPAT9 suppresses cell growth, invasion and metastasis by counteracting acidic tumor microenvironment through KLF4/LASS2/V-ATPase signaling pathway in breast cancer [J]. Oncotarget, 2015, 6(21): 18406-18417.
[17] Zou P, Yang Y, Xu X, et al. Silencing of vacuolar ATPase c subunit ATP6V0C inhibits the invasion of prostate cancer cells through a LASS2/TMSG1-independent manner [J]. Oncol Rep, 2018, 39(1): 298-306.
[18] Yang Y, Yang X, Li L, et al. LASS2 inhibits proliferation and induces apoptosis in HepG2 cells by affecting mitochondrial dynamics, the cell cycle and the nuclear factor?κB pathways [J]. Oncol Rep, 2019, 41(5): 3005-3014.
[19] 袁远, 黄恩应, 陈小刚. LASS2在膀胱癌组织中的表达及对细胞增殖和侵袭能力的影响[J]. 福建医科大学学报, 2018, 52(5): 311-315.
[20] 李时荣, 伊日贵, 左华楚, 等. 人类长寿保障基因2/肿瘤转移抑制基因1基因过表达对人肺癌细胞的影响[J]. 中华实验外科杂志, 2017, 34(7): 1252-1253. LI Shirong, YI Rigrui, ZUO Huachu, et al. Effects of homo sapiens longevity assurance homologue 2/tumor metastasis suppressor gene 1 gene overexpression on human lung cancer cells [J]. Chinese Journal of Experimental Surgery, 2017, 34(7): 1252-1253.
[21] Wang H, Zuo Y, Ding M, et al. LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity [J]. Oncol Lett, 2017, 13(2): 661-668.
[22] Gu D, Jin H, Jin G, et al. The asialoglycoprotein receptor suppresses the metastasis of hepatocellular carcinoma via LASS2-mediated inhibition of V-ATPase activity [J]. Cancer Lett, 2016, 379(1): 107-116.
[23] Ke RH, Wang Y, Mao Y, et al. Decreased expression of LASS2 is associated with worse prognosis in meningiomas [J]. J Neurooncol, 2014, 118(2): 369-376.
[24] Ruan H, Wang T, Yang C, et al. Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma [J]. Sci Rep, 2016, 6(9): 1-9.
[25] Sheng N, Wang Y, Xie Y, et al. High expression of LASS2 is associated with unfavorable prognosis in patients with ovarian cancer [J]. J Cell Physiol, 2019, 234(8): 13001-13013.
[1] ZHENG Su, CHEN Shuhua, LI Hua, DENG Jie, CHEN Chunhong, WANG Xiaohui, FENG Weixing, HAN Xiaodi, ZHANG Yujia, LI Na, LI Mo, FANG Fang. Correlation between EEG variations and BASED evaluation of the efficacy of ACTH treatment in 54 cases of infantile spasms [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 91-96.
[2] WANG Lihui, GAO Min, KONG Beihua. Angiosarcoma of the uterus: a report of 2 cases and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 108-112.
[3] HE Shiqing, LI Wanwan, DONG Shuqing, MOU Jingyi, LIU Yuying, WEI Siyu, LIU Zhao, ZHANG Jiaxin. Construction of a prognostic risk model of pyroptosis-related genes in breast cancer based on database [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 34-43.
[4] ZHANG Yufeng, XU Min, XING Xiuli, PANG Shuguang, HU Keqing. Epidemiological characteristics of 689 patients with non-ST-segment elevation myocardial infarction [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 118-122.
[5] LI Linlin, WANG Kai. Prediction of hepatocellular carcinoma prognostic genes based on bioinformatics [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 50-58.
[6] CHU Yan, LIU Duanrui, ZHU Wenshuai, FAN Rong, MA Xiaoli, WANG Yunshan, JIA Yanfei. Expressions of DNA methyltransferases in gastric cancer and their clinical significance [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 1-9.
[7] CHEN Liyu, XIAO Juan, LYU Xianzhong, DUAN Baomin, HONG Fanzhen. Risk factors influencing prognosis of lower extremity deep vein thrombosis in pregnant and parturient women [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 38-42.
[8] TIAN Yaotian, WANG Bao, LI Yeqin, WANG Teng, TIAN Liwen, HAN Bo, WANG Cuiyan. Machine learning models based on interpretive CMR parameters can predict the prognosis of pediatric myocarditis [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 43-49.
[9] LI Wanwan, ZHOU Wenkai, DONG Shuqing, HE Shiqing, LIU Zhao, ZHANG Jiaxin, LIU Bin. Construct of a risk assessment model of breast cancer immune-related lncRNAs based on the database information [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 74-84.
[10] SUN Fuyun, WANG Weipeng, ZHANG Huihui, GENG Yan, AN Xiaoxia, LI Shuangshuang, ZHANG Binbin. Correlation among personality traits and depression, anxiety symptoms in patients after colorectal cancer resection [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 91-96.
[11] MI Qi, SHI Shuang, LI Juan, LI Peilong, DU Lutao, WANG Chuanxin. Construction of circRNA-mediated ceRNA network and prognostic assessment model for bladder cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 94-102.
[12] LI Xiangqing, YIN Xin, ZHAO Xuelian, ZHAO Peiqing. Expression and clinical significance of circulating CD56bright subset of NK cells in patients with Parkinsons disease [J]. Journal of Shandong University (Health Sciences), 2021, 59(2): 34-40.
[13] ZENG Rui, HU Xinting, YUN Xiaoya, TIAN Zheng, LI Qing, LIU Jie, ZHANG Ya, WANG Xin. Fluorescence in situ hybridization in the diagnosis of 197 cases of chronic lymphocytic leukemia [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 35-40.
[14] DU Tiantian, LI Juan, ZHAO Yinghui, DUAN Weili, WANG Jing, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression profiles of long non-coding RNA LINC02474 and effects on cell proliferation in colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 57-67.
[15] LI Yinglin, SONG Daoqing, XU Zhonghua. Identification of FKBP11 expression in clear cell renal cell carcinoma using bioinformatics analysis [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 45-51.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd